A detailed history of Algert Global LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Algert Global LLC holds 45,430 shares of IONS stock, worth $1.66 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
45,430
Previous 75,350 39.71%
Holding current value
$1.66 Million
Previous $3.59 Million 49.32%
% of portfolio
0.05%
Previous 0.12%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$40.06 - $51.86 $1.2 Million - $1.55 Million
-29,920 Reduced 39.71%
45,430 $1.82 Million
Q2 2024

Aug 14, 2024

BUY
$36.45 - $47.7 $1.64 Million - $2.15 Million
45,108 Added 149.16%
75,350 $3.59 Million
Q1 2024

May 14, 2024

BUY
$42.03 - $53.55 $539,244 - $687,046
12,830 Added 73.68%
30,242 $1.31 Million
Q4 2023

Feb 14, 2024

SELL
$43.39 - $51.63 $1.22 Million - $1.45 Million
-28,110 Reduced 61.75%
17,412 $881,000
Q3 2023

Nov 13, 2023

SELL
$38.5 - $47.13 $143,605 - $175,794
-3,730 Reduced 7.57%
45,522 $2.07 Million
Q2 2023

Aug 14, 2023

SELL
$34.73 - $43.33 $326,461 - $407,302
-9,400 Reduced 16.03%
49,252 $2.02 Million
Q1 2023

May 12, 2023

SELL
$33.58 - $41.2 $500,174 - $613,674
-14,895 Reduced 20.25%
58,652 $2.1 Million
Q4 2022

Feb 13, 2023

BUY
$37.12 - $46.52 $468,083 - $586,617
12,610 Added 20.69%
73,547 $2.78 Million
Q3 2022

Nov 15, 2022

BUY
$36.54 - $48.66 $1.32 Million - $1.75 Million
36,037 Added 144.73%
60,937 $2.7 Million
Q2 2022

Aug 15, 2022

BUY
$31.71 - $43.0 $366,440 - $496,908
11,556 Added 86.6%
24,900 $922,000
Q1 2022

May 16, 2022

SELL
$29.88 - $37.04 $749,569 - $929,185
-25,086 Reduced 65.28%
13,344 $494,000
Q4 2021

Feb 14, 2022

BUY
$25.61 - $35.1 $383,023 - $524,955
14,956 Added 63.71%
38,430 $1.17 Million
Q3 2021

Nov 15, 2021

BUY
$33.54 - $40.55 $787,317 - $951,870
23,474 New
23,474 $787,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.19B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.